SUHIX Fees and Costs — DWS Health and Wellness Fund, Institutional Class
Data updated: 2026-09-24
The net expense ratio is 1.04%: a 0.77% management fee plus 0.30% other expenses, less a 0.03% fee waiver. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $7K in broker commissions, 0.0029% of average net assets, and portfolio turnover was 2%.
SUHIX Fees and Expenses
Annual operating expenses and sales charges of SUHIX. Prospectus, as of September 24, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.77% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.30% |
| Gross expense ratio | 1.07% |
| Fee waiver | −0.03% |
| Net expense ratio | 1.04% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
SUHIX Costs Over Time
On $10,000 invested in SUHIX, assuming 5% a year before costs, total costs come to $652 over 5 years, cutting the return by 1.10% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 1.04%) | $109 | $341 | $590 |
| Trading costs (broker commissions) | $0 | $1 | $2 |
| Lost growth on money paid in costs | $0 | $17 | $60 |
| Total costs | $110 | $358 | $652 |
| Value after costs | $10,390 | $11,218 | $12,111 |
| Impact on return, per year | 1.10% | 1.10% | 1.10% |
SUHIX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending May 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0029%
- Total broker commissions: $7K
- Bought from dealers (principal trades, not a cost): $76.3M
- Portfolio turnover (prospectus): 2%
- Securities on loan, average value: $1.6M
- Net income from securities lending: $7K (0.003% of average net assets)
SUHIX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| J.P. Morgan Securities LLC | $2K | 27.89% |
| UBS Securities LLC | $1K | 15.27% |
| Morgan Stanley & Co. LLC | $971 | 13.62% |
| Scotia Capital (USA) Inc. | $806 | 11.30% |
| BofA Securities, Inc. | $790 | 11.07% |
| RBC Capital Markets, LLC | $425 | 5.95% |
| Goldman Sachs & Co. LLC | $399 | 5.59% |
| Citigroup Global Markets Inc. | $355 | 4.97% |
| Mizuho Securities USA LLC | $309 | 4.33% |
SUHIX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| State Street Bank and Trust Company | $76.2M | 99.83% |
| Apellis Pharmaceuticals, Inc. | $131K | 0.17% |
DWS Health and Wellness Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| SUHIX | Institutional Class | 1.04% | none |
| SCHLX | Class S | 1.06% | none |
| SUHAX | Class A | 1.34% | 5.75% |
| SUHCX | Class C | 2.09% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.